Clinical trial
A Phase 1, 2-Stage, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 Following Single and Multiple Ascending Doses in Healthy Adult Subjects
NCT03830125 is registered in ClinicalTrials.gov with Bridge Biotherapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, 2-Stage, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 Following Single and Multiple Ascending Doses in Healthy Adult Subjects
- Lead sponsor
- Bridge Biotherapeutics, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 13, 2019
- Completion date
- November 24, 2019
- Enrollment
- 88 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.